Evidence map›Paper›PMID 34445309›Full record

ArticleInternational journal of molecular sciences2021

Analysis of

Vladimir Sobolev, Anastasia Nesterova, Anna Soboleva, Alexandre Mezentsev, Evgenia Dvoriankova, Anastas Piruzyan, Elena Denisova, Olga Melnichenko, Irina Korsunskaya

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. PPARs as Key Mediators in the Regulation of Metabolism and Inflammation.International journal of molecular sciences · 2022
    Article
  15. The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion.Clinical, cosmetic and investigational dermatology · 2022
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Vladimir SobolevI. Mechnikov Research Institute for Vaccines and Sera RAMS, Russian Federation, Malyy Kazennyy Lane, 5, 105064 Moscow, Russia.ORCID 0000-0003-4779-156X
Anastasia NesterovaLife Science Research and Development Department, Elsevier Inc., Rockville, MD 20850, USA.ORCID 0000-0002-9448-8101
Anna SobolevaCentre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Srednyaya Kalitnikovskaya Street, 30, 109029 Moscow, Russia.ORCID 0000-0002-9158-1933
Alexandre MezentsevI. Mechnikov Research Institute for Vaccines and Sera RAMS, Russian Federation, Malyy Kazennyy Lane, 5, 105064 Moscow, Russia.
Evgenia DvoriankovaCentre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Srednyaya Kalitnikovskaya Street, 30, 109029 Moscow, Russia.
Anastas PiruzyanCentre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Srednyaya Kalitnikovskaya Street, 30, 109029 Moscow, Russia.
Elena DenisovaCentre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Srednyaya Kalitnikovskaya Street, 30, 109029 Moscow, Russia.
Olga MelnichenkoMoscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Russian Federation, 17, Leninskiy Avenue, 119071 Moscow, Russia.ORCID 0000-0002-0522-3225
Irina KorsunskayaCentre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Russian Federation, Srednyaya Kalitnikovskaya Street, 30, 109029 Moscow, Russia.
Center for Theoretical Problems of Physicochemical Pharmacology · RURELX Group (United States) · USState Research Center for Dermatovenereology and Cosmetology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our previous work, we built the model of

Indexed as

Signal TransductionAdultFemaleForkhead Transcription FactorsFos-Related Antigen 1HumansInterleukin-17MaleMiddle AgedNuclear Receptor Subfamily 1, Group F, Member 3PPAR gammaProto-Oncogene Proteins c-fosPsoriasisSTAT3 Transcription FactorT-LymphocytesForkhead Transcription FactorsFos-Related Antigen 1FOXP3 protein, humanInterleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3PPAR gammaProto-Oncogene Proteins c-fosRORC protein, humanSTAT3 protein, humanSTAT3 Transcription FactorELISAimmunohistochemistryperoxisome proliferator-activated receptor gamma (PPARγ)psoriasisreal-time PCRsignaling pathway

Identifiers

PMID34445309
PMCPMC8395241
OpenAlexW3187218953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.